Golovan et al., 2016 - Google Patents
Antiviral activity of a substance from yeast RNAGolovan et al., 2016
View PDF- Document ID
- 15555876476435473322
- Author
- Golovan A
- Naumenko K
- Melnichuk N
- Baranova G
- Tkachuk Z
- Zagorodnya S
- Publication year
External Links
Snippet
RNA based drugs are used in clinic for treatment of infectious diseases as immunomodulators and antiviral agents. Nuclex is low molecular weight exogenous yeast RNA that consists of a pure homogeneous 25-membered oligonucleotide. The preventive …
- 230000000840 anti-viral 0 title abstract description 21
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Piret et al. | Clinical development of letermovir and maribavir: Overview of human cytomegalovirus drug resistance | |
| Ahmad et al. | Autophagy-virus interplay: from cell biology to human disease | |
| Camargo et al. | Emerging concepts in cytomegalovirus infection following hematopoietic stem cell transplantation | |
| DeStefano et al. | Management of post‐transplant lymphoproliferative disorders | |
| Wu et al. | Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin | |
| De Clercq | Antivirals: past, present and future | |
| Antoine et al. | Glycoprotein targeted therapeutics: a new era of anti‐herpes simplex virus‐1 therapeutics | |
| Lin et al. | Inhibitory effects of some derivatives of glycyrrhizic acid against Epstein-Barr virus infection: Structure–activity relationships | |
| Wiedinger et al. | Reactivation of human polyomaviruses in immunocompromised states | |
| EA201270632A1 (en) | 2'-Fluoro-6'-Methylene Carbocyclic Nucleosides and Methods for the Treatment of Viral Infections | |
| Troszok et al. | Acyclovir inhibits Cyprinid herpesvirus 3 multiplication in vitro | |
| Anagha et al. | Scope of Glycyrrhiza glabra (Yashtimadhu) as an antiviral agent: a review | |
| Priengprom et al. | Synergistic effects of acyclovir and 3, 19-isopropylideneandrographolide on herpes simplex virus wild types and drug-resistant strains | |
| Wu et al. | Antiviral activity of topoisomerase II catalytic inhibitors against Epstein–Barr virus | |
| Pompei et al. | Antiviral properties of glycyrrhizic acid and its semisynthetic derivatives | |
| Cohen | Licking latency with licorice | |
| Golovan et al. | Antiviral activity of a substance from yeast RNA | |
| Kongyingyoes et al. | 3, 19-isopropylideneandrographolide suppresses early gene expression of drug-resistant and wild type herpes simplex viruses | |
| JPH0285215A (en) | Treatment method for hepatitis B with antiviral drugs | |
| Liao et al. | The second-generation XPO1 inhibitor eltanexor inhibits human cytomegalovirus (HCMV) replication and promotes type I interferon response | |
| Martinez et al. | High mutation rate in SARS-CoV-2: will it hit us the same way forever | |
| Kumar | 5-(1-Substituted) alkyl pyrimidine nucleosides as antiviral (herpes) agents | |
| Yan et al. | Salvianolic acid A acts as a herpes simplex virus dual inhibitor by blocking glycoprotein B-mediated adsorption and membrane fusion | |
| RU2533232C2 (en) | Using polycarboxylic fullerene deriative as microbiocidal antiviral agent | |
| Domingo-Calap | Viral evolution and Immune responses |